Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

2.

0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.

Reitamo S, Harper J, Bos JD, Cambazard F, Bruijnzeel-Koomen C, Valk P, Smith C, Moss C, Dobozy A, Palatsi R; European Tacrolimus Ointment Group.

Br J Dermatol. 2004 Mar;150(3):554-62.

PMID:
15030341
3.

A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo.

Lepe V, Moncada B, Castanedo-Cazares JP, Torres-Alvarez MB, Ortiz CA, Torres-Rubalcava AB.

Arch Dermatol. 2003 May;139(5):581-5.

PMID:
12756094
4.

Efficacy of topical tacrolimus 0.3% in clobetasol propionate 0.05% ointment in therapy-resistant cutaneous lupus erythematosus: a cohort study.

Madan V, August PJ, Chalmers RJ.

Clin Exp Dermatol. 2010 Jan;35(1):27-30. doi: 10.1111/j.1365-2230.2009.03351.x. Epub 2009 Jun 22.

PMID:
19549244
5.

Comparative efficacy of tacrolimus 0.1% ointment and clobetasol propionate 0.05% ointment in oral lichen planus: a randomized double-blind trial.

Sonthalia S, Singal A.

Int J Dermatol. 2012 Nov;51(11):1371-8. doi: 10.1111/j.1365-4632.2012.05459.x.

PMID:
23067089
6.

Comparative effect of tacrolimus 0.1% ointment and clobetasol 0.05% ointment in patients with oral lichen planus.

Corrocher G, Di Lorenzo G, Martinelli N, Mansueto P, Biasi D, Nocini PF, Lombardo G, Fior A, Corrocher R, Bambara LM, Gelio S, Pacor ML.

J Clin Periodontol. 2008 Mar;35(3):244-9. doi: 10.1111/j.1600-051X.2007.01191.x.

PMID:
18269664
7.

Comparison of topical tacrolimus 0.1 % in pectin ointment with clobetasol 0.5% ointment in adults with moderate to severe desquamative gingivitis: A 4-week, randomized, double-blind clinical trial.

Corrocher G, Di Lorenzo G, Mansueto P, Martinelli N, Esposito-Pellitteri M, Gelio S, Lombardo G, Pacor ML.

Clin Ther. 2006 Sep;28(9):1296-302.

PMID:
17062302
8.

Successful treatment with topical tacrolimus in four cases of discoid lupus erythematosus.

Sugano M, Shintani Y, Kobayashi K, Sakakibara N, Isomura I, Morita A.

J Dermatol. 2006 Dec;33(12):887-91.

PMID:
17169097
9.

Topical tacrolimus therapy of resistant cutaneous lesions in lupus erythematosus: a possible alternative.

Lampropoulos CE, Sangle S, Harrison P, Hughes GR, D'Cruz DP.

Rheumatology (Oxford). 2004 Nov;43(11):1383-5. Epub 2004 Jul 20.

PMID:
15266063
10.

Pimecrolimus 1% cream versus betamethasone 17-valerate 0.1% cream in the treatment of facial discoid lupus erythematosus: a double-blind, randomized pilot study.

Barikbin B, Givrad S, Yousefi M, Eskandari F.

Clin Exp Dermatol. 2009 Oct;34(7):776-80. doi: 10.1111/j.1365-2230.2008.03138.x. Epub 2009 May 18.

PMID:
19456797
11.

Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.

Doss N, Reitamo S, Dubertret L, Fekete GL, Kamoun MR, Lahfa M, Ortonne JP.

Br J Dermatol. 2009 Aug;161(2):427-34. doi: 10.1111/j.1365-2133.2009.09143.x. Epub 2009 Apr 16.

PMID:
19416227
12.

A comparative treatment study of topical tacrolimus and clobetasol in oral lichen planus.

Radfar L, Wild RC, Suresh L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008 Feb;105(2):187-93. doi: 10.1016/j.tripleo.2007.07.029.

PMID:
18230389
13.

Evaluation of the efficacy and safety of clobetasol propionate spray in the treatment of plaque-type psoriasis.

Jarratt MT, Clark SD, Savin RC, Swinyer LJ, Safley CF, Brodell RT, Yu K.

Cutis. 2006 Nov;78(5):348-54.

PMID:
17186795
14.

Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation.

Tzellos TG, Kouvelas D.

Eur J Clin Pharmacol. 2008 Apr;64(4):337-41. Epub 2007 Dec 20. Review.

PMID:
18157526
15.

A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis.

Lebwohl M, Sherer D, Washenik K, Krueger GG, Menter A, Koo J, Feldman SR.

Int J Dermatol. 2002 May;41(5):269-74.

PMID:
12100701
16.

A multicenter trial of the efficacy and safety of 0.03% tacrolimus ointment for atopic dermatitis in Korea.

Won CH, Seo PG, Park YM, Yang JM, Lee KH, Sung KJ, Park CW, Kim DW, Chang HS, Won YH, Kim KH.

J Dermatolog Treat. 2004 Jan;15(1):30-4.

PMID:
14754647
17.

Efficacy and safety of methylprednisolone aceponate ointment 0.1% compared to tacrolimus 0.03% in children and adolescents with an acute flare of severe atopic dermatitis.

Bieber T, Vick K, Fölster-Holst R, Belloni-Fortina A, Städtler G, Worm M, Arcangeli F.

Allergy. 2007 Feb;62(2):184-9.

18.

A double-blind, randomized, placebo-controlled trial of topical tacrolimus 0·1% vs. clobetasol propionate 0·05% in childhood vitiligo.

Ho N, Pope E, Weinstein M, Greenberg S, Webster C, Krafchik BR.

Br J Dermatol. 2011 Sep;165(3):626-32. doi: 10.1111/j.1365-2133.2011.10351.x. Epub 2011 Jun 30.

PMID:
21457214
19.

Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.

Singalavanija S, Noppakun N, Limpongsanuruk W, Wisuthsarewong W, Aunhachoke K, Chunharas A, Wananukul S, Akaraphanth R.

J Med Assoc Thai. 2006 Nov;89(11):1915-22.

PMID:
17205874
20.

Clobetasol propionate followed by calcipotriol is superior to calcipotriol alone in topical treatment of psoriasis.

Austad J, Bjerke JR, Gjertsen BT, Helland S, Livden JK, Morken T, Mørk NJ.

J Eur Acad Dermatol Venereol. 1998 Jul;11(1):19-24.

PMID:
9731961

Supplemental Content

Support Center